OhioHealth hospital was the first to use the FDA Approved Drug, Ocrevus

                                                                  

Medical staff at OhioHealth’s Neuroscience Center at Riverside Methodist Hospital became the first in the world to treat patients with a new FDA drug called Ocrevus in the battle against multiple sclerosis.

The significance of the drug lies in how it can slow what’s called primary progressive multiple sclerosis. The manufacturer, Genentech, says it is the first and only disease-modifying therapy for primary progressive multiple sclerosis or PPMS.

Watch the WBNS 10-TV story about the drug above. 

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews